派林生物
(000403)
| 流通市值：171.87亿 | | | 总市值：173.64亿 |
| 流通股本：9.41亿 | | | 总股本：9.50亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 666,259,948.78 | 1,321,124,262.61 | 754,186,603.94 | 850,349,304.1 |
| 应收票据及应收账款 | 508,906,181.4 | 668,989,985.91 | 579,108,848.4 | 519,268,700.61 |
| 其中：应收票据 | 24,616,664.52 | 37,768,154.86 | 7,932,995.11 | 5,755,681.11 |
| 应收账款 | 484,289,516.88 | 631,221,831.05 | 571,175,853.29 | 513,513,019.5 |
| 应收款项融资 | 29,980,323.29 | 41,696,512.81 | 13,203,838.86 | 14,445,934.66 |
| 预付款项 | 51,499,291.61 | 23,011,355.24 | 46,060,757.91 | 21,832,161.84 |
| 其他应收款合计 | 7,393,205.3 | 6,155,410.75 | 8,372,736.88 | 13,586,580.3 |
| 其中:应收利息 | 1,827,991.83 | 1,627,397.26 | 1,479,452.05 | 1,479,452.05 |
| 存货 | 1,436,677,512.89 | 1,233,248,553.27 | 1,139,194,714.69 | 1,139,640,065.04 |
| 其他流动资产 | 16,902,103.02 | 2,020,116.68 | 1,990,316.21 | 7,241,621.68 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 3,469,649,834.08 | 3,578,948,533.75 | 3,542,327,499.32 | 3,419,669,292.38 |
| 非流动资产: | | | | |
| 长期应收款 | 600,000,000 | 600,000,000 | 600,000,000 | 600,000,000 |
| 其他非流动金融资产 | 6,000,000 | 6,000,000 | - | - |
| 投资性房地产 | 297,634.31 | 304,754.27 | 311,874.23 | 318,994.19 |
| 固定资产 | 1,501,906,582.14 | 1,462,342,887.3 | 1,373,956,195.97 | 1,066,897,008.9 |
| 在建工程 | 516,422,273.4 | 513,359,045.14 | 463,311,557.62 | 670,464,323.37 |
| 使用权资产 | 21,899,793.92 | 23,452,859.61 | 25,006,305.98 | 26,380,198.93 |
| 无形资产 | 195,982,845.01 | 200,333,103.32 | 203,906,755.23 | 208,912,472.36 |
| 开发支出 | 131,852,297.21 | 109,769,448.82 | 92,103,597.55 | 77,952,200.48 |
| 商誉 | 2,614,611,614.12 | 2,614,611,614.12 | 2,614,611,614.12 | 2,614,611,614.12 |
| 长期待摊费用 | 43,356,819.26 | 43,781,684.62 | 9,443,653.11 | 10,414,211.28 |
| 递延所得税资产 | 30,023,008.02 | 29,425,352.78 | 41,043,900.39 | 39,857,692.88 |
| 其他非流动资产 | 64,698,137.38 | 63,940,081.53 | 87,193,349.45 | 101,199,249.14 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 5,727,051,004.77 | 5,667,320,831.51 | 5,510,888,803.65 | 5,417,007,965.65 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 9,196,700,838.85 | 9,246,269,365.26 | 9,053,216,302.97 | 8,836,677,258.03 |
| 流动负债: | | | | |
| 短期借款 | 297,001,776.42 | 310,489,207.3 | 265,698,040.33 | 249,161,048.96 |
| 交易性金融负债 | - | - | - | 29,125,658.05 |
| 应付票据及应付账款 | 185,200,789.24 | 224,256,183.28 | 178,491,158.71 | 227,295,153.03 |
| 其中：应付票据 | 15,839,722.56 | 3,931,864.18 | - | - |
| 应付账款 | 169,361,066.68 | 220,324,319.1 | 178,491,158.71 | 227,295,153.03 |
| 合同负债 | 6,734,628.71 | 6,357,121.1 | 9,684,977.64 | 27,152,147 |
| 应付职工薪酬 | 23,782,054.98 | 73,521,208.02 | 31,492,784.63 | 37,162,446.71 |
| 应交税费 | 38,917,393.99 | 48,616,877.13 | 54,976,186.36 | 42,919,434.49 |
| 其他应付款合计 | 220,027,480.51 | 256,664,579.36 | 288,087,246.09 | 264,715,022.26 |
| 应付股利 | 1,472,493.32 | 1,472,493.32 | 1,007,905.37 | 849,568.02 |
| 一年内到期的非流动负债 | 45,518,786.24 | 22,119,759.35 | 37,219,818.8 | 39,930,140.6 |
| 其他流动负债 | 10,683,869.24 | 14,946,816.74 | 5,806,402.28 | 2,712,941.04 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 827,866,779.33 | 956,971,752.28 | 871,456,614.84 | 920,173,992.14 |
| 非流动负债: | | | | |
| 长期借款 | 294,842,822.5 | 303,221,491.31 | 271,227,337.53 | 222,545,337.53 |
| 租赁负债 | 17,196,758.85 | 18,604,949.28 | 22,034,052.35 | 20,327,754.68 |
| 长期应付款 | 9,000,000 | 9,000,000 | 9,000,000 | 9,000,000 |
| 递延收益 | 26,419,638.8 | 26,843,315.63 | 33,479,292.75 | 34,217,852.58 |
| 递延所得税负债 | 14,933,363.65 | 14,125,221.41 | 21,192,151.77 | 21,359,022.96 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 362,392,583.8 | 371,794,977.63 | 356,932,834.4 | 307,449,967.75 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 1,190,259,363.13 | 1,328,766,729.91 | 1,228,389,449.24 | 1,227,623,959.89 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 731,074,913 | 731,074,913 | 733,043,291 | 733,043,291 |
| 资本公积 | 4,758,215,262.16 | 4,758,215,262.16 | 4,796,355,404.07 | 4,796,355,404.07 |
| 减:库存股 | - | - | 40,108,519.91 | 40,108,519.91 |
| 其他综合收益 | 53,564.36 | 54,271.67 | 40,943.34 | 50,043.65 |
| 盈余公积 | 159,123,167.84 | 159,123,167.84 | 133,435,422.24 | 133,435,422.24 |
| 未分配利润 | 2,365,272,352.53 | 2,276,183,136.88 | 2,208,944,306.43 | 1,993,195,756.29 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 8,013,739,259.89 | 7,924,650,751.55 | 7,831,710,847.17 | 7,615,971,397.34 |
| 少数股东权益 | -7,297,784.17 | -7,148,116.2 | -6,883,993.44 | -6,918,099.2 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 8,006,441,475.72 | 7,917,502,635.35 | 7,824,826,853.73 | 7,609,053,298.14 |
| 负债和股东权益合计 | 9,196,700,838.85 | 9,246,269,365.26 | 9,053,216,302.97 | 8,836,677,258.03 |
| 公告日期 | 2025-04-24 | 2025-04-24 | 2024-10-28 | 2024-08-28 |
| 审计意见(境内) | | 标准无保留意见 | | |